Clinical Trial Update: Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating a single escalating dose of ACRX-100 in adults with ischemic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Failure

Drugs mentioned

• ACRX-100 (ACRX-100)

Snippet

Sponsor: Juventas Therapeutics, Inc. | Conditions: Heart Failure | Phase 1 | Status: COMPLETED